It's what we've all been dreaming of: a way to combine one of the most promising future MS treatments with the crap we're currently stuck with!
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2008 May 7
Makar TK, Trisler D, Bever CT, Goolsby JE, Sura KT, Balasubramanian S, Sultana S, Patel N, Ford D, Singh IS, Gupta A, Valenzuela RM, Dhib-Jalbut S.
VA Maryland Healthcare System, Baltimore, MD ...